Epstein-barr Virus-associated Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus-associated Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) [Phase 1, Phase 2]
A Phase 1/2 trial of tabelecleucel in combination with pembrolizumab for Epstein-Barr virus-associated nasopharyngeal carcinoma was terminat…